市場調查報告書
商品編碼
1028212

生物外科手術市場:現狀分析與預測(2021年∼2027年)

Biosurgery Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在各種手術中,生物外科產品用來減少手術中和手術後的問題。標準傷口閉合材料(例如縫合線和釘針)的低效使用是手術和外傷患者失血的主要原因之一。世界範圍內事故頻率上升導致需要大量運行時間的手術數量增加。因此,在外科手術過程中對適當的失血管理產品的需求大幅增加。此外,外科手術的進步和新產品的推出,幫助外科醫生有效地進行手術,預計將進一步推動市場。

本報告提供全球生物外科手術市場調查,市場概要,各產品、用途、地區的詳細趨勢,前幾名Start-Ups企業,新型冠狀病毒感染疾病(COVID-19)對市場的影響,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 市場調查範圍

第2章 調查手法或前提條件

第3章 市場概要

第4章 摘要整理

第5章 生物外科手術產業前幾名Start-Ups企業

第6章 新型冠狀病毒感染疾病(COVID-19)的影響

第7章 全球生物外科手術市場收益

第8章 全球生物外科手術市場洞察:各產品

  • 外科用密封膠
  • 止血劑
  • 防沾黏貼片
  • 軟組織附件
  • 骨移植附件

第9章 全球生物外科手術市場洞察:各用途

  • 一般外科
  • 整形外科
  • 心血管外科
  • 腦神經外科
  • 其他(重組術,泌尿科,婦產科外科)

第10章 全球生物外科手術市場洞察:各終端用戶

  • 醫院
  • 診所
  • 其他

第11章 全球生物外科手術市場洞察:各地區

  • 北美的生物外科手術市場
    • 美國
    • 加拿大
    • 其他
  • 歐洲的生物外科手術市場
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的生物外科手術市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他地區

第12章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第13章 相關法規

第14章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 合併、收購

第15章 價值鏈分析

第16章 市場機會

第17章 市場趨勢 & 洞察

第18章 競爭模式

  • 波特的五力分析
  • 競爭情形

第19章 企業概要

  • Medtronic PLC
    • 主要資訊
    • 營業內容
    • 主要的產品、服務
    • 成長策略
    • SWOT分析
    • 財務資訊
    • 近幾年趨勢
  • Johnson & Johnson (Ethicon)
  • Strykers
  • Baxter International Inc.
  • C.R. Bard
  • Sanofi
  • Pfizer
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Zimmer Biomet

第20章 免責聲明

目錄
Product Code: UMHE21339

In various surgeries, biosurgery products are utilized to reduce intra- and post-operative problems. The inefficient use of standard wound closure materials, such as sutures and staples, is one of the leading causes of blood loss in surgical and trauma patients. The rising frequency of accidents around the world has resulted in an increase in the number of procedures requiring extensive operating hours. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed. As per an article published by National Library of Medicine, in 2019, uncontrolled hemorrhage is the leading cause of preventable death that occurs due to injury. Similarly, as per National Trauma Institute, after a traumatic injury, hemorrhage is responsible for over 35% of pre-hospital deaths and over 40% of deaths within the first 24 hours of the injury. The number of surgeries that involve long operating times is increasing. In such a scenario, there is a growing demand for effective blood loss management products.

Furthermore, advancements in surgeries and novel product launch to help surgeons perform surgeries efficiently are expected to further fuel the market.

Based on product, the global Biosurgery market is bifurcated into surgical sealants, hemostatic agents, adhesion barriers, soft tissue attachments, and bone graft attachments. Currently, bone graft attachments testing segment dominated the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing use of bone graft substitute products in orthopedic and dental surgeries and significant benefits offered by bone graft substitute products over conventional autograft products.

Based on application the market is divided into general Surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, and others (reconstructive, urology, and gynecology surgeries). Orthopedic surgery dominated the market in 2020 owing to prevalence of bone diseases, and cases of road accidents. However, cardiovascular surgery is expected to grow at a fast pace during the forecast period owing to the prevalence of diabetes and heart disease.

Based on end-user the market is bifurcated into hospitals, clinics, and others. Currently hospitals segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Netherlands, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America constitutes a major market for Biosurgery owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include Johnson & Johnson (Ethicon), Medtronic Plc, Strykers, Baxter International Inc., C.R. Bard, Sanofi, Pfizer, B. Braun Melsungen AG, Integra Lifesciences Corporation, and Zimmer Biomet.

Global Biosurgery Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Biosurgery Market is expected to witness a boost on account of the increasing prevalence chronics disease and increasing road accidents.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Biosurgery Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Biosurgery Market
    • 2.1.1 Main Objective of the Global Biosurgery Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER BIOSURGERY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL BIOSURGERY MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

  • 8.1 Surgical Sealants
  • 8.2 Hemostatic Agents
  • 8.3 Adhesion Barriers
  • 8.4 Soft Tissue Attachments
  • 8.5 Bone Graft Attachments

9 MARKET INSIGHTS BY APPLICATION

  • 9.1 General Surgery
  • 9.2 Orthopedic Surgery
  • 9.3 Cardiovascular surgery
  • 9.4 Neurological Surgery
  • 9.5 Others (Reconstructive, Urology, and Gynecology Surgeries)

10 MARKET INSIGHTS BY END-USER

  • 10.1 Hospitals
  • 10.2 Clinics
  • 10.3 Others

11 MARKET INSIGHTS BY REGION

  • 11.1 NORTH AMERICA BIOSURGERY MARKET
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 EUROPE BIOSURGERY MARKET
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 United Kingdom
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 ASIA PACIFIC BIOSURGERY MARKET
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.5 Rest of Asia Pacific
  • 11.4 REST OF THE WORLD BIOSURGERY MARKET

12 BIOSURGERY MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis
    • 14.2.1 Top Product Launches
    • 14.2.2 Top Business Partnerships
    • 14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 BIOSURGERY MARKET OPPORTUNITIES

17 BIOSURGERY MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1 Porter's Five forces analysis
    • 18.1.1 Bargaining power of Supplier
    • 18.1.2 Bargaining power of Buyer
    • 18.1.3 Industry Rivalry
    • 18.1.4 Availability of Substitute
    • 18.1.5 Threat of new Entrants
  • 18.2 Competitive Landscape
    • 18.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

  • 19.1 Medtronic PLC
    • 19.1.1 Key Facts
    • 19.1.2 Business Description
    • 19.1.3 Key Product/Services Offerings
    • 19.1.4 Growth Strategy
    • 19.1.5 SWOT Analysis
    • 19.1.6 Key Financials
      • 19.1.6.1 Revenue Split
      • 19.1.6.2 Financial Overview of Medtronics plc
    • 19.1.7 Recent Developments
      • 19.1.7.1 Product Launch
      • 19.1.7.2 Partnerships
      • 19.1.7.3 Business Expansion and Investments
      • 19.1.7.4 Merger and Acquisition
  • 19.2 Johnson & Johnson (Ethicon)
  • 19.3 Strykers
  • 19.4 Baxter International Inc.
  • 19.5 C.R. Bard
  • 19.6 Sanofi
  • 19.7 Pfizer
  • 19.8 B. Braun Melsungen AG
  • 19.9 Integra Lifesciences Corporation
  • 19.10 Zimmer Biomet

20 DISCLAIMER